Afelimomab-another therapeutic option in sepsis therapy?

Crit Care Med. 2004 Nov;32(11):2343-4. doi: 10.1097/01.ccm.0000146134.86536.2f.
No abstract available

Publication types

  • Editorial
  • Meta-Analysis
  • Review
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Critical Care / methods
  • Critical Care / standards
  • Evidence-Based Medicine
  • Humans
  • Interleukin-6 / blood*
  • Patient Selection*
  • Sepsis / blood*
  • Sepsis / drug therapy*
  • Sepsis / immunology
  • Sepsis / mortality
  • Survival Rate
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Interleukin-6
  • afelimomab